Trastuzumab deruxtecan

trastuzumab  Trastuzumab emtansine binds to the HER2 receptor's sub-domain IV and goes into the cell by receptor-mediated endocytosis Lysosomes degrade trastuzumab หน้าแรก · ประกาศการจัดซื้อจัดจ้าง; ประกวดราคาการจัดซื้อเวชภัณฑ์ยา Trastuzumab 440 mg จำนวน 60 vial ด้วยวิธีประกวดราคาอิเล็กทรอนิกส์

Key Message The ShortHER trial failed to demonstrate the non-inferiority of 9 weeks versus 1 year of adjuvant trastuzumab combined with chemotherapy The short Comment: Trastuzumab is a humanized IgG1κ monoclonal antibody targeting HER2 Annotated peptide sequences for this antibody are available from its IMGTmAb-DB

Descriptions Trastuzumab injection is used to treat HER2-overexpressing new or metastatic breast cancer It can be CONCLUSION: Administering higher doses on a 3-weekly schedule did not compromise the efficacy and safety of trastuzumab in women with HER2-positive MBC, and